Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corporation Plc Sponsored ADR | 0.54% | 18.49 | 1.8% | $136.66m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 0.77% | 91.23 | 18.6% | $96.63m | |
| SAGE | SAGE Therapeutics, Inc. | -1.51% | 164.46 | 8.8% | $79.59m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.28% | 129.42 | 2.3% | $71.74m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | -2.74% | 161.03 | 6.3% | $58.17m | |
| PRGO | Perrigo Co. Plc | -0.75% | 49.19 | 6.8% | $54.20m | |
| ZGNX | Zogenix, Inc. | 1.79% | 38.06 | 9.9% | $47.79m | |
| UTHR | United Therapeutics Corporation | -0.78% | 103.50 | 14.3% | $44.63m | |
| CTLT | Catalent Inc | -0.02% | 44.44 | 2.4% | $40.01m | |
| HZNP | Horizon Pharma plc | -0.48% | 25.14 | 6.7% | $34.23m | |
| PTLA | Portola Pharmaceuticals, Inc. | 1.02% | 35.76 | 7.6% | $33.53m | |
| ICLR | ICON Plc | -0.28% | 134.67 | 4.1% | $31.06m | |
| ZYNE | Zynerba Pharmaceuticals Inc | 1.11% | 10.01 | 8.3% | $29.64m | |
| MYOK | MyoKardia, Inc. | -2.81% | 47.69 | 2.1% | $25.34m | |
| MNK | Mallinckrodt Plc | -0.87% | 18.20 | 21.0% | $24.91m |
Company Profile
Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.